Samir Abu-Rumeileh
Overview
Explore the profile of Samir Abu-Rumeileh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abu-Rumeileh S, Scholle L, Mensch A, Grosskopf H, Ratti A, Kolsch A, et al.
Nat Commun
. 2025 Mar;
16(1):2019.
PMID: 40044663
Blood phosphorylated (p)-tau 181 and p-tau 217 have been proposed as accurate biomarkers of Alzheimer's disease (AD) pathology. However, blood p-tau 181 is also elevated in amyotrophic lateral sclerosis (ALS)...
2.
Thaele A, Barba L, Abu-Rumeileh S, Foschi M, Otto M
Epilepsy Behav
. 2025 Feb;
165:110321.
PMID: 39983592
Epileptology - with epilepsy as one of the most common neurological diseases - has an urgent need for easily accessible biomarkers to improve diagnosis, prognosis and therapeutic monitoring. Neurofilament light...
3.
Barba L, Vollmuth C, Halbgebauer S, Ungethum K, Hametner C, Essig F, et al.
Eur J Neurol
. 2024 Dec;
32(1):e16581.
PMID: 39714176
Background: We aimed to investigate the prognostic role of β-synuclein in comparison to that of neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) for predicting functional outcome after...
4.
Barba L, Gaetani L, Sperandei S, Di Sabatino E, Abu-Rumeileh S, Halbgebauer S, et al.
J Neurol
. 2024 Dec;
272(1):85.
PMID: 39708160
Background: People with multiple sclerosis (PwMS) experience various degrees of cognitive impairment (CI). Synaptic dysfunction may contribute to CI in PwMS but cerebrospinal fluid (CSF) synaptic biomarkers are unexplored in...
5.
de San Jose N, Halbgebauer S, Steinacker P, Anderl-Straub S, Abu-Rumeileh S, Barba L, et al.
Transl Neurodegener
. 2024 Nov;
13(1):57.
PMID: 39614344
No abstract available.
6.
Abu-Rumeileh S, Arajyan G, Reiman E, Otto M, Weise C
Alzheimers Dement
. 2024 Aug;
20(10):7411-7419.
PMID: 39177111
Introduction: The in vivo detection of mixed Alzheimer's disease (AD) and α-synuclein (αSyn) pathology is important for clinical management and prognostic stratification. We investigated the contribution of αSyn pathology, detected...
7.
Barba L, Abu-Rumeileh S, Barthel H, Massa F, Foschi M, Bellomo G, et al.
Brain
. 2024 Jul;
147(10):3325-3343.
PMID: 38991041
Concomitant Alzheimer's disease (AD) pathology is a frequent event in the context of Lewy body disease (LBD), occurring in approximately half of all cases. Evidence shows that LBD patients with...
8.
DAnna L, Abu-Rumeileh S, Merlino G, Ornello R, Foschi M, Diana F, et al.
J Am Heart Assoc
. 2024 Jun;
13(17):e034783.
PMID: 38874062
There is limited evidence on the outcomes and safety of mechanical thrombectomy (MT) among patients with acute ischemic stroke (AIS) in the context of cardiac diseases. Our study reviews MT...
9.
Barba L, Bellomo G, Oeckl P, Chiasserini D, Gaetani L, Torrigiani E, et al.
J Neurol Sci
. 2024 Jun;
462:123059.
PMID: 38850771
Background: VGF and neuroserpin are neurosecretory proteins involved in the pathophysiology of neurodegenerative diseases. We aimed to evaluate their cerebrospinal fluid (CSF) concentrations in patients with Alzheimer's disease (AD) and...
10.
DAnna L, Merlino G, Romoli M, Zhang L, Del Regno C, Aggour M, et al.
J Neurol
. 2024 May;
271(8):4925-4932.
PMID: 38753228
Background: There is a lack of data regarding patients aged 90 years or older undergoing mechanical thrombectomy and their predictors of futile recanalization. Aims: We sought to evaluate the predictors...